The new R&D centre will be spearheaded by Revela’s founding team, including co-founder and CEO Dr Evan Zhao, who will hold the position of chief scientific officer. “We have seen the transformational powers of biotechnology and artificial intelligence on drug discovery, and are unleashing these technologies in the beauty and wellness space with massive investment,” said Oran Holtzman, co-founder and CEO of Oddity. “While our competitors are stuck in the past, adding Revela will allow us to build the future of R&D for the category.”
